Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Duke University
With
Siemens Medical Solutions
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
1. Oncology patients with castrate-resistant prostate cancer planned for therapy with abiraterone acetate or enzalutamide and prednisolone undergoing clinically indicated MDCT (multi-detector computed tomography) of the chest, abdomen and pelvis
2. \> 18 years old
3. Serum creatinine \< 2.0
4. BMI \< 35kg/m\^2
5. Sign informed consent
You may not be if
\- History of anaphylactoid reaction to iodinated contrast material
Clareo Health | Applications of Dual Energy CT in Patients With Osseous Metastases From Castrate-resistant Prostate Cancer
